Page last updated: 2024-08-23

silybin and Angiogenesis, Pathologic

silybin has been researched along with Angiogenesis, Pathologic in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's4 (30.77)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Mehrabani, M; Mohammadi, C; Najafi, R; Sameri, S1
Karas, D; Pivodová, V; Ulrichova, J; Valentová, K; Zahler, S1
Agarwal, R; Chittezhath, M; Deep, G; Raina, K; Rajamanickam, S; Singh, RP1
Agarwal, R; Raina, K; Sharma, G; Singh, RP1
Agarwal, R; Dwyer-Nield, LD; Malkinson, AM; Radcliffe, RA; Raina, K; Ramasamy, K; Redente, EF; Singh, RP; Tyagi, A1
Agarwal, R; Kaur, M; Rajamanickam, S; Singh, RP; Velmurugan, B1
Agarwal, R; Dwyer-Nield, LD; Hasebroock, KM; Malkinson, AM; Raina, K; Ramasamy, K; Serkova, NJ; Singh, RP; Tyagi, A1
Agarwal, R; Nambiar, D; Prajapati, V; Singh, RP1
Agarwal, C; Agarwal, R; Dhanalakshmi, S; Singh, RP1
Agarwal, R; Chittezhath, M; Deep, G; Dwyer-Nield, LD; Kaur, M; Malkinson, AM; Singh, RP1
Agarwal, C; Agarwal, R; Dhanalakshmi, S; Gu, M; Singh, RP1
Agarwal, R; Mohan, S; Sharma, G; Singh, RP; Tyagi, A1
Agarwal, R; Gu, M; Singh, RP1

Other Studies

13 other study(ies) available for silybin and Angiogenesis, Pathologic

ArticleYear
Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.
    BMC complementary medicine and therapies, 2021, May-31, Volume: 21, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Mice; Neovascularization, Pathologic; Silybin

2021
    Die Pharmazie, 2016, 08-01, Volume: 71, Issue:8

    Topics: Angiogenesis Inhibitors; Cell Cycle; Cell Proliferation; Endothelial Cells; Esters; Gallic Acid; Humans; MAP Kinase Signaling System; Microtubules; Neovascularization, Pathologic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Silybin; Silymarin; Structure-Activity Relationship

2016
Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Cancer research, 2008, Aug-15, Volume: 68, Issue:16

    Topics: Adenocarcinoma; Animals; Antioxidants; Apoptosis; Biomarkers, Tumor; Blotting, Western; Body Weight; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Female; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Neoplasm Staging; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Silybin; Silybum marianum; Silymarin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2008
Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-01, Volume: 14, Issue:23

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blotting, Western; Cadherins; Cell Proliferation; Disease Progression; Immunohistochemistry; Male; Matrix Metalloproteinases; Mice; Mice, Transgenic; Neoplasm Metastasis; Neovascularization, Pathologic; Prostatic Neoplasms; Silybin; Silymarin; Vimentin

2008
Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
    Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:1

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Proliferation; Cytokines; Enzyme-Linked Immunosorbent Assay; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Lung Neoplasms; Macrophages; Male; Mice; Microvessels; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Silybin; Silymarin; STAT3 Transcription Factor

2009
Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
    Cancer research, 2010, Mar-15, Volume: 70, Issue:6

    Topics: Adenomatous Polyposis Coli; Animals; Antioxidants; Apoptosis; beta Catenin; Cell Growth Processes; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Intestinal Polyps; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Silybin; Silymarin; Transcriptional Activation

2010
Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Feb-15, Volume: 17, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Cell Proliferation; Down-Regulation; Gene Deletion; Intermediate Filament Proteins; Lung; Lung Neoplasms; Male; Mice; Mice, Knockout; Neovascularization, Pathologic; Nerve Tissue Proteins; Nestin; NF-kappa B; Nitric Oxide Synthase Type II; Silybin; Silymarin; STAT3 Transcription Factor; Tumor Burden; Urethane; Vascular Endothelial Growth Factor Receptor-2; X-Ray Microtomography

2011
In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
    Cancer letters, 2013, Jun-28, Volume: 334, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Humans; Male; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; Silybin; Silymarin; Xenograft Model Antitumor Assays

2013
Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
    Oncogene, 2005, Feb-10, Volume: 24, Issue:7

    Topics: Angiogenesis Inhibitors; Apoptosis; Biological Assay; Cell Cycle; Cell Movement; Cells, Cultured; Collagen; Down-Regulation; Drug Combinations; Endothelium, Vascular; Humans; Inhibitor of Apoptosis Proteins; Laminin; Membrane Potentials; Microtubule-Associated Proteins; Mitochondria; Neoplasm Proteins; Neovascularization, Pathologic; NF-kappa B; Protein Serine-Threonine Kinases; Proteoglycans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Silybin; Silymarin; Survivin

2005
Effect of silibinin on the growth and progression of primary lung tumors in mice.
    Journal of the National Cancer Institute, 2006, Jun-21, Volume: 98, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinogens; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Disease Models, Animal; Fibroblast Growth Factor 2; Immunohistochemistry; Inflammation; Lung Neoplasms; Mice; Microcirculation; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Silybin; Silymarin; Urethane; Vascular Endothelial Growth Factor A

2006
Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice.
    Cancer research, 2007, Apr-01, Volume: 67, Issue:7

    Topics: Animals; Antioxidants; Cell Growth Processes; Cell Nucleus; Cell Transformation, Neoplastic; Cyclooxygenase 2; Female; Inflammation; Mice; Mice, Hairless; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Silybin; Silymarin; Skin; Skin Neoplasms; STAT3 Transcription Factor; Ultraviolet Rays

2007
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jan-01, Volume: 14, Issue:1

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Proliferation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Microtubule-Associated Proteins; Neovascularization, Pathologic; Repressor Proteins; Silybin; Silymarin; Survivin; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2008
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
    Cancer research, 2008, Mar-15, Volume: 68, Issue:6

    Topics: Animals; Antioxidants; Apoptosis; Cell Growth Processes; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 2; Enzyme Activation; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oncogene Protein v-akt; Silybin; Silymarin; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2008